Immunotherapy Makes a Difference in Relapsed Hodgkin Lymphoma – Targeted Oncology
|
Immunotherapy Makes a Difference in Relapsed Hodgkin Lymphoma
Targeted Oncology Briones, chief of the Hematology Service, Hospital de la Santa Creu i Sant Pau in Barcelona, Spain, discussed the rationale for treating patients with Hodgkin lymphoma with 3 immunotherapy approaches during the 2nd Annual European Congress on … |
